1-20 of 327
Shaji Kumar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, and MAIA

Clinical Trials & Observations
Michele Cavo, Jesus San-Miguel, Saad Z. Usmani, Katja Weisel, Meletios A. Dimopoulos, Hervé Avet-Loiseau, Bruno Paiva, Nizar J. Bahlis, Torben Plesner, Vania Hungria, Philippe Moreau, Maria-Victoria Mateos, Aurore Perrot, Shinsuke Iida, Thierry Facon, Shaji Kumar, Niels W. C. J. van de Donk, Pieter Sonneveld, Andrew Spencer, Maria Krevvata, Christoph Heuck, Jianping Wang, Jon Ukropec, Rachel Kobos, Steven Sun, Mia Qi, Nikhil Munshi
Journal: Blood
Blood (2022) 139 (6): 835–844.
DOI: https://doi.org/10.1182/blood.2021011101
Published: 2022
Includes: Supplemental data
Journal Articles

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

Clinical Trials & Observations
Jesus San-Miguel, Hervé Avet-Loiseau, Bruno Paiva, Shaji Kumar, Meletios A. Dimopoulos, Thierry Facon, María-Victoria Mateos, Cyrille Touzeau, Andrzej Jakubowiak, Saad Z. Usmani, Gordon Cook, Michele Cavo, Hang Quach, Jon Ukropec, Priya Ramaswami, Huiling Pei, Mia Qi, Steven Sun, Jianping Wang, Maria Krevvata, Nikki DeAngelis, Christoph Heuck, Rian Van Rampelbergh, Anupa Kudva, Rachel Kobos, Ming Qi, Nizar J. Bahlis
Journal: Blood
Blood (2022) 139 (4): 492–501.
DOI: https://doi.org/10.1182/blood.2020010439
Published: 2022
Includes: Supplemental data
Journal Articles

First-Line Use of Daratumumab, Lenalidomide, and Dexamethasone Confers Survival Benefit Compared with Second-Line Use of Daratumumab-Based Regimens in Transplant-Ineligible Patients with Multiple Myeloma: Analysis of Different Clinical Scenarios

Rafael Fonseca, Thierry Facon, Mahmoud Hashim, Sandhya Nair, Jianming He, Eric M. Ammann, Annette Lam, Mark Wildgust, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 118.
DOI: https://doi.org/10.1182/blood-2021-144914
Published: 2021
Journal Articles

Mortality Trends in Multiple Myeloma after the Introduction of Novel Therapies in the United States

Bharat Nandakumar, Moritz Binder, S. Vincent Rajkumar, Prashant Kapoor, Francis K. Buadi, David Dingli, Martha Q. Lacy, Morie A. Gertz, Suzanne R. Hayman, Nelson Leung, Amie Fonder, Miriam A. Hobbs, Yi L. Hwa, Eli Muchtar, Rahma M Warsame, Taxiarchis Kourelis, Wilson I Gonsalves, Stephen J. Russell, Yi Lin, Mustaqeem A. Siddiqui, Robert A. Kyle, Angela Dispenzieri, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 119.
DOI: https://doi.org/10.1182/blood-2021-146894
Published: 2021
Journal Articles

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplant (ASCT) for Patients with POEMS Syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes): A CIBMTR Analysis

Ankit Kansagra, Angela Dispenzieri, Raphael Fraser, Noel Estrada-Merly, Shaji Kumar, Muzaffar H. Qazilbash, Nina Shah, Anita D'Souza
Journal: Blood
Blood (2021) 138 (Supplement 1): 120.
DOI: https://doi.org/10.1182/blood-2021-151325
Published: 2021
Journal Articles

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma

Julia E. Wiedmeier, Madiha Iqbal, Javier Munoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, Patrick B. Johnston, Matthew Hathcock, Jeremy T. Larsen, P. Leif Bergsagel, Yucai Wang, Craig B. Reeder, Jose F. Leis, Rafael Fonseca, Jeanne M. Palmer, Rahma M Warsame, Taxiarchis Kourelis, Suzanne R. Hayman, David Dingli, Prashant Kapoor, Shaji Kumar, Urshila Durani, Jose C. Villasboas, Jonas Paludo, N. Nora Bennani, Stephen M. Ansell, Januario E Castro, Mohamed A. Kharfan-Dabaja, Yi Lin, Paschalis Vergidis, Hemant S. Murthy, Allison C. Rosenthal
Journal: Blood
Blood (2021) 138 (Supplement 1): 1750.
DOI: https://doi.org/10.1182/blood-2021-151859
Published: 2021
Journal Articles

Establishing a Novel Pipeline That Combines in-Silico Prediction with in-Vitro and Ex-Vivo V alidation to Discover Secondary Drug Combinations Against Relapsed and/or Refractory Multiple Myeloma

Sayak Chakravarti, Suman Mazumder, Harish Kumar, Neeraj Sharma, Ujjal Kumar Mukherjee, Shaji Kumar, Linda B Baughn, Brian G. Van Ness, Amit Kumar Mitra
Journal: Blood
Blood (2021) 138 (Supplement 1): 1615.
DOI: https://doi.org/10.1182/blood-2021-154521
Published: 2021
Journal Articles

Monoclonal Proteinuria Predicts Progression Risk in Asymptomatic Multiple Myeloma with a Free Light Chain Ratio ≥100

Alissa Visram, S. Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson I Gonsalves, Rahma M Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1617.
DOI: https://doi.org/10.1182/blood-2021-152557
Published: 2021
Journal Articles

The Prognostic Utility of Serial MASS-FIX in Multiple Myeloma

Nadine Abdallah, David L Murray, Angela Dispenzieri, Prashant Kapoor, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Wilson I Gonsalves, Eli Muchtar, Nelson Leung, David Dingli, Taxiarchis Kourelis, Rahma M Warsame, Moritz Binder, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1619.
DOI: https://doi.org/10.1182/blood-2021-153326
Published: 2021
Journal Articles

Factors Associated with Renal Impairment at Diagnosis in Multiple Myeloma with Survival Trends over Last Two Decades

Sagar Rakshit, Radhika Bansal, Prashant Kapoor, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Yi L. Hwa, Amie Fonder, Miriam A. Hobbs, Wilson I Gonsalves, Eli Muchtar, David Dingli, Taxiarchis Kourelis, Rahma M Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar, Nelson Leung
Journal: Blood
Blood (2021) 138 (Supplement 1): 1630.
DOI: https://doi.org/10.1182/blood-2021-153512
Published: 2021
Journal Articles

Outcomes of Triple Class (Proteasome Inhibitor, IMiDs and Monoclonal Antibody) Refractory Patients with Multiple Myeloma

Saurabh Zanwar, Matthew Ho, Prashant Kapoor, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Amie Fonder, Yi L. Hwa, Miriam A. Hobbs, Wilson I Gonsalves, Rahma M Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1632.
DOI: https://doi.org/10.1182/blood-2021-145085
Published: 2021
Journal Articles

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Multiple Myeloma Patients at Mayo Clinic

Scott Soefje, Corinne Carpenter, Katherine Carlson, Samir Awasthi, Thomas S. Lin, Shuchita Kaila, Daniel Tarjan, Nikhil Kayal, Christian Kirkup, Tyler Wagner, Kathleen Gray, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2717.
DOI: https://doi.org/10.1182/blood-2021-149012
Published: 2021
Journal Articles

Graded Cardiac Response Criteria for AL Amyloidosis: The Impact of Depth of Cardiac Response on Survival

Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Kaya Veelken, Ute Hegenbart, Shaji Kumar, Efstathios Kastritis, Meletios A. Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzsch, Alexander Coltoff, Joan Bladé, M. Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh D. Wechalekar, Morie A. Gertz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2720.
DOI: https://doi.org/10.1182/blood-2021-149222
Published: 2021
Journal Articles

Graded Renal Response Criteria for Light Chain (AL) Amyloidosis

Eli Muchtar, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Kaya Veelken, Ute Hegenbart, Angela Dispenzieri, Shaji Kumar, Nelson Leung, Efstathios Kastritis, Meletios A. Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzsch, Alexander Coltoff, Joan Bladé, M. Teresa Cibeira, Oliver C Cohen, Darren Foard, Julian D Gillmore, Helen J Lachmann, Ashutosh D. Wechalekar, Morie A. Gertz
Journal: Blood
Blood (2021) 138 (Supplement 1): 2721.
DOI: https://doi.org/10.1182/blood-2021-149594
Published: 2021
Journal Articles

Late vs Early Response and Depth of Response Are Associated with Improved Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) or Placebo-Lenalidomide-Dexamethasone (pbo-Rd) in the Phase 3 TOURMALINE-MM2 Trial

Paul G. Richardson, Thierry Facon, Christopher P. Venner, Nizar J. Bahlis, Fritz Offner, Darrell White, Lionel Karlin, Lotfi Benboubker, Sophie Rigaudeau, Eric Voog, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Arun Kumar, Philip Twumasi-Ankrah, Richard Labotka, Robert M. Rifkin, Sagar Lonial, Shaji Kumar, S. Vincent Rajkumar, Philippe Moreau
Journal: Blood
Blood (2021) 138 (Supplement 1): 2733.
DOI: https://doi.org/10.1182/blood-2021-148481
Published: 2021
Journal Articles

Trial in Progress: Phase I Open-Label Study of Metformin and Nelfinavir in Combination with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma

Wilson I Gonsalves, Shaji Kumar, Gabriela Perez, Stephanie Saathoff, Diana M Wilson, Anna Young, Sikander Ailawadhi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2735.
DOI: https://doi.org/10.1182/blood-2021-149437
Published: 2021
Journal Articles

Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma

Sagar Lonial, Stefano R. Tarantolo, Ralph V. Boccia, Habte Yimer, Moshe Y. Levy, Rafat Abonour, Meera Mohan, Vivek Roy, Jeremy T. Larsen, Saulius K. Girnius, Cara A. Rosenbaum, Omar Nadeem, Deborah Berg, Bo Chao, Allison J Berger, Akito Nakamura, Yuhong Zhang, Keli Song, Christine K. Ward, Igor Proscurshim, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2742.
DOI: https://doi.org/10.1182/blood-2021-148385
Published: 2021
Journal Articles

Can Patient-Reported Ocular Symptoms Guide Dose Modifications in Patients with Relapsed/Refractory Multiple Myeloma Receiving Belantamab Mafodotin?

Rakesh Popat, Ashraf Z. Badros, Shaji Kumar, Paula Rodríguez-Otero, Adam D. Cohen, Salomon Manier, Peter M. Voorhees, Francesca Gay, Robert M. Rifkin, Thomas Martin, Ajai Chari, Katja Weisel, Asim V. Farooq, Bennie H. Jeng, Wee Joo Chng, Hans C. Lee, Jesus Berdeja, Vinay Jadhav, Alessandra Tosolini, Laurie Eliason, Antonio Palumbo, Meletios A. Dimopoulos, Sagar Lonial, Suzanne Trudel, Paul G. Richardson, Evangelos Terpos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2746.
DOI: https://doi.org/10.1182/blood-2021-152681
Published: 2021
Journal Articles

Mgta-145 + Plerixafor Provides GCSF-Free Rapid and Reliable Hematopoietic Stem Cell Mobilization for Autologous Stem Cell Transplant in Patients with Multiple Myeloma: A Phase 2 Study

Surbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, Shaji Kumar, John Tamaresis, Anne Le, Lori Muffly, Laura J. Johnston, Sally Arai, Robert Lowsky, Everett H Meyer, Andrew R. Rezvani, Wen-Kai Weng, Matthew J. Frank, Parveen Shiraz, Douglas Girgenti, Kevin A. Goncalves, Veit Schmelmer, John C. Davis, Jr., Ying Lu, Judith A Shizuru, David B. Miklos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3885.
DOI: https://doi.org/10.1182/blood-2021-149306
Published: 2021
Journal Articles

Single Cell Transcriptome Profile of Myeloma and Immune Cell Characteristics in Patients with Durable Response Post CART

Yan Asmann, Ying Li, Taxiarchis Kourelis, Moritz Binder, Wilson I Gonsalves, Henan Zhang, Anatilde Gonzalez Guerrico, Zuoyi Shao, Prashant Kapoor, David Dingli, Rahma M Warsame, Haidong Dong, Shaji Kumar, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3838.
DOI: https://doi.org/10.1182/blood-2021-153254
Published: 2021